Xueyan Zhang

4PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 07, 2026
Multi-omics dynamic profiling reveals predictive biomarkers for first-line immunochemotherapy in extensive-stage small-cell lung cancer.

Liang Zheng, Haoming Xu, Shuyuan Wang

|Mar 26, 2025
Efficacy and safety of autologous CIK cell therapy plus Toripalimab with or without chemotherapy in advanced NSCLC: A phase II study.

Runbo Zhong, Tianqing Chu, Liwen Xiong

|Sep 11, 2024
The prognosis and metabolite changes of NSCLC patients receiving first-line immunotherapy combined chemotherapy in different M1c categories according to 9th edition of TNM classification.

Liang Zheng, Fang Hu, Wei Nie

|Apr 19, 2024
Association of metabolomics with PD-1 inhibitor plus chemotherapy outcomes in patients with advanced non-small-cell lung cancer.

Liang Zheng, Fang Hu, Lin Huang

Pageof 1

Frequent Collaborators

2 joint publications

Runbo Zhong

1 joint publications

Baohui Han

1 joint publications

Wei Zhang

1 joint publications

Baohui Han